Kristina Boye, Associate Vice President, Value, Evidence, and Outcomes, Eli Lilly and Company
Advertisement
Articles by Kristina Boye, Associate Vice President, Value, Evidence, and Outcomes, Eli Lilly and Company
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
FDA Updates Sotatercept Label with HYPERION Data in Early PAH
2
Half-Life vs. Real Life: How Real-World Evidence Is Reframing Wet AMD Treatment
3
FAQ: What the Expanded Marstacimab Approval Means for Hemophilia A, B
4
EMBARQ-CSU: Barzolvolimab Meets Primary, Secondary Endpoints in CSU Trials
5